Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19

Violetta Dymicka-Piekarska,1,* Justyna Dorf,1,* Anna Milewska,2 Mateusz Łukaszyk,3 Jakub Wiktor Kosidło,4 Joanna Kamińska,1 Blanka Wolszczak-Biedrzycka,5 Wojciech Naumnik3 1Department of Clinical Laboratory Diagnostics, Medical University of Bialystok...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Dymicka-Piekarska V (Author), Dorf J (Author), Milewska A (Author), Łukaszyk M (Author), Kosidło JW (Author), Kamińska J (Author), Wolszczak-Biedrzycka B (Author), Naumnik W (Author)
Hōputu: Pukapuka
I whakaputaina: Dove Medical Press, 2023-05-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3d6a3f287c4e4b50a56ebae79dbe7f73
042 |a dc 
100 1 0 |a Dymicka-Piekarska V  |e author 
700 1 0 |a Dorf J  |e author 
700 1 0 |a Milewska A  |e author 
700 1 0 |a Łukaszyk M  |e author 
700 1 0 |a Kosidło JW  |e author 
700 1 0 |a Kamińska J  |e author 
700 1 0 |a Wolszczak-Biedrzycka B  |e author 
700 1 0 |a Naumnik W  |e author 
245 0 0 |a Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19 
260 |b Dove Medical Press,   |c 2023-05-01T00:00:00Z. 
500 |a 1178-7031 
520 |a Violetta Dymicka-Piekarska,1,* Justyna Dorf,1,* Anna Milewska,2 Mateusz Łukaszyk,3 Jakub Wiktor Kosidło,4 Joanna Kamińska,1 Blanka Wolszczak-Biedrzycka,5 Wojciech Naumnik3 1Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, Poland; 2Department of Biostatistics and Medical Informatics, Medical University of Bialystok, Białystok, Poland; 3Temporary Hospital No 2 of Clinical Hospital in Bialystok, 1st Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Białystok, Poland; 4Students Scientific Club at the Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland; 5Department of Psychology and Sociology of Health and Public Health, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland*These authors contributed equally to this workCorrespondence: Violetta Dymicka-Piekarska, Email piekarskav@yahoo.comAim: The aim of our retrospective study was search for new prognostic parameters, which can help quickly and cheaply identify patients with risk for severe course of SARS-CoV-2 infection.Materials and Methods: The following peripheral blood combination biomarkers were calculated: NLR (neutrophil/lymphocytes ratio), LMR (lymphocyte/monocyte ratio), PLR (platelet/lymphocyte ratio), dNLR (neutrophils/(white blood cells − neutrophils)), NLPR (neutrophil/(lymphocyte × platelet ratio)) in 374 patients who were admitted to the Temporary Hospital no 2 of Clinical Hospital in Bialystok (Poland) with COVID-19. The patients were divided into four groups depending on the severity of the course of COVID-19 using MEWS classification.Results: The NLR and dNLR were significantly increased with the severity of COVID-19, according to MEWS score. The AUC for the assessed parameters was higher in predicting death in patients with COVID-19: NLR (0.656, p=0.0018, cut-off=6.22), dNLR (0.615, p=0.02, cut-off=3.52) and LMR (0.609, p=0.03, cut-off=2.06). Multivariate COX regression analysis showed that NLR median above 5.56 (OR: 1.050, P=0.002), LMR median below 2.23 (OR: 1.021, P=0.011), and age > 75 years old (OR: 1.072, P=0.000) had a significant association with high risk of death during COVID-19.Conclusion: Our results indicate that NLR, dNLR, and LMR calculated on admission to the hospital can quickly and easy identify patients with risk of a more severe course of COVID-19. Increase NLR and decrease LMR have a significant predictive value in COVID-19 patient's mortality and might be a potential biomarker for predicting death in COVID-19 patients.Keywords: COVID-19, biomarker, mortality, NLR, dNLR, LMR, PLR 
546 |a EN 
690 |a covid-19 
690 |a biomarker 
690 |a mortality 
690 |a nlr 
690 |a dnlr 
690 |a lmr 
690 |a plr 
690 |a Pathology 
690 |a RB1-214 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Inflammation Research, Vol Volume 16, Pp 2209-2222 (2023) 
787 0 |n https://www.dovepress.com/neutrophillymphocyte-ratio-nlr-and-lymphocytemonocyte-ratio-lmr--risk--peer-reviewed-fulltext-article-JIR 
787 0 |n https://doaj.org/toc/1178-7031 
856 4 1 |u https://doaj.org/article/3d6a3f287c4e4b50a56ebae79dbe7f73  |z Connect to this object online.